Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
Zhao F, Siu MK, Jiang L, Tam KF, Ngan HY, Le XF, Wong OG, Wong ES, Chan HY, Cheung AN.
Histopathology. 2011 Dec;59(6):1163-72. doi: 10.1111/j.1365-2559.2011.04045.x.
Related citations
Fascin expression in low-grade uterine endometrioid adenocarcinoma: correlation with microcystic, elongated and fragmented (MELF)-type alteration at the deep invasive margin.
Stewart CJ, Crook ML, Manso L.
Histopathology. 2011 Jul;59(1):73-80. doi: 10.1111/j.1365-2559.2011.03893.x.
Human epidermal growth factor receptor 2 overexpression and amplification in mucinous tumours of ovary.
Gilks CB, McAlpine J.
Histopathology. 2011 Jun;58(7):1173-4. doi: 10.1111/j.1365-2559.2011.03865.x. No abstract available.
Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival.
Lenhard M, Lennerová T, Ditsch N, Kahlert S, Friese K, Mayr D, Jeschke U.
Histopathology. 2011 May;58(6):990-4. doi: 10.1111/j.1365-2559.2011.03848.x. No abstract available.
IGFBP-1 is expressed specifically in ovarian clear cell adenocarcinoma.
Sugita S, Morishita Y, Kano J, Furuya S, Shiba-Ishii A, Noguchi M.
Histopathology. 2011 Apr;58(5):729-38. doi: 10.1111/j.1365-2559.2011.03817.x. Epub 2011 Apr 4.
Nuclear localization of E-cadherin but not beta-catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma.
Ohishi Y, Oda Y, Kurihara S, Kaku T, Kobayashi H, Wake N, Tsuneyoshi M.
Histopathology. 2011 Feb;58(3):423-32. doi: 10.1111/j.1365-2559.2011.03761.x. Epub 2011 Feb 7.
HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target.
Han CP, Hsu JD, Yao CC, Lee MY, Ruan A, Tyan YS, Yang SF, Chiang H.
Histopathology. 2010 Nov;57(5):763-4. doi: 10.1111/j.1365-2559.2010.03689.x. No abstract available. Erratum in: Histopathology. 2011 Feb;58(3):506.
Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours.
Kim TH, Kim YK, Kwon Y, Heo JH, Kang H, Kim G, An HJ.
Histopathology. 2010 Nov;57(5):734-43. doi: 10.1111/j.1365-2559.2010.03686.x.
Expression of aberrantly glycosylated Mucin-1 in ovarian cancer.
Van Elssen CH, Frings PW, Bot FJ, Van de Vijver KK, Huls MB, Meek B, Hupperets P, Germeraad WT, Bos GM.
Histopathology. 2010 Oct;57(4):597-606. doi: 10.1111/j.1365-2559.2010.03667.x.
Array comparative genomic hybridization analysis indicates that serous carcinomas of the ovary, fallopian tube and endometrium are distinct entities.
Nowee ME, Seeber LM, Horrée N, Snijders AM, Van Diest PJ, Verheijen RH, Dorsman JC.
Histopathology. 2010 Oct;57(4):634-7. doi: 10.1111/j.1365-2559.2010.03656.x. No abstract available.
Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation.
Kim KR, Choi J, Hwang JE, Baik YA, Shim JY, Kim YM, Robboy SJ.
Histopathology. 2010 Oct;57(4):587-96. doi: 10.1111/j.1365-2559.2010.03673.x.
Juvenile granulosa cell tumour with hepatocyte-like cells and raised serum alpha-fetoprotein.
Smith R, Moss J, Shore I, El-Bahrawy MA.
Histopathology. 2010 Oct;57(4):637-41. doi: 10.1111/j.1365-2559.2010.03662.x. Epub 2010 Sep 28. No abstract available.
Methylation profiles of hereditary and sporadic ovarian cancer.
Bol GM, Suijkerbuijk KP, Bart J, Vooijs M, van der Wall E, van Diest PJ.
Histopathology. 2010 Sep;57(3):363-70. doi: 10.1111/j.1365-2559.2010.03642.x. Epub 2010 Aug 31.
Error occurred: cannot get document summary
Risk factors in thyroid-type carcinoma arising in ovarian struma: a report of 15 cases with comparison to ordinary struma ovarii.
Roth LM, Talerman A, Wadsley J, Karseladze AI.
Histopathology. 2010 Jul;57(1):148-52. No abstract available.
Micro-anatomical variation in cellular proliferation in endometrial adenocarcinoma, and inverse correlation between Ki67 and cytokeratin 7 expression.
Stewart CJ, Crook ML, Doherty DA.
Histopathology. 2010 Jul;57(1):46-54. Epub 2010 Jun 14.
Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns.
Zynger DL, McCallum JC, Luan C, Chou PM, Yang XJ.
Histopathology. 2010 May;56(6):750-7.
Cumulative alterations of p27-related cell-cycle regulators in the development of endometriosis-associated ovarian clear cell adenocarcinoma.
Yamamoto S, Tsuda H, Miyai K, Takano M, Tamai S, Matsubara O.
Histopathology. 2010 May;56(6):740-9.
Expression of classical NF-kappaB pathway effectors in human ovarian carcinoma.
Darb-Esfahani S, Sinn BV, Weichert W, Budczies J, Lehmann A, Noske A, Buckendahl AC, Müller BM, Sehouli J, Koensgen D, Györffy B, Dietel M, Denkert C.
Histopathology. 2010 May;56(6):727-39.
Functioning extraovarian stromal luteinization of the peritoneum.
Aneiros-Fernández J, Carballo P, Molina S, Muñoz E, Nogales FF.
Histopathology. 2010 Apr;56(5):654-6. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on